| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000165133.84978.E2 |
| P698 | PubMed publication ID | 15883213 |
| P50 | author | Vanesa Esteban | Q38641526 |
| Juan Rodriguez-Vita | Q58774280 | ||
| P2093 | author name string | Jesús Egido | |
| Marta Ruiz-Ortega | |||
| Elsa Sánchez-López | |||
| Mónica Rupérez | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2509-2517 | |
| P577 | publication date | 2005-05-09 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism | |
| P478 | volume | 111 |
| Q53605893 | A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. |
| Q47824296 | A mutation update on the LDS associated genes TGFB2/3 and SMAD2/3. |
| Q42957610 | A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats |
| Q36846132 | Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats |
| Q35916617 | Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode |
| Q42037037 | Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm |
| Q61854900 | Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation |
| Q41353200 | Angiotensin II induces connective tissue growth factor expression in human hepatic stellate cells by a transforming growth factor β-independent mechanism |
| Q34990858 | Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism |
| Q37410582 | Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis |
| Q91860388 | Angiotensin II-induced micro RNA-21 culprit for non-small-cell lung adenocarcinoma |
| Q36310340 | Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases |
| Q37250548 | Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q55266983 | Angiotensin, transforming growth factor β and aortic dilatation in Marfan syndrome: Of mice and humans. |
| Q54333854 | Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. |
| Q37410646 | Aortic aneurysms in Loeys-Dietz syndrome - a tale of two pathways? |
| Q41988051 | Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade. |
| Q39001215 | Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling |
| Q34559487 | Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. |
| Q30609102 | BMP signaling modulation attenuates cerebral arteriovenous malformation formation in a vertebrate model |
| Q88419528 | Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models |
| Q33360714 | Blocking of angiotensin II is more than blocking of transforming growth factor-beta |
| Q38148988 | Can antihypertensive medication interfere with the vicious cycle between hypertension and vascular calcification? |
| Q26796244 | Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications |
| Q36560968 | Cardiometabolic syndrome and chronic kidney disease |
| Q37595599 | Cardiovascular effects of losartan and its relevant clinical application |
| Q26798487 | Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities |
| Q37626424 | Cellular and molecular mechanisms of thoracic aortic aneurysms |
| Q33914103 | Chronic obstructive sleep apnea promotes aortic remodeling in canines through miR-145/Smad3 signaling pathway |
| Q46867288 | Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts |
| Q42859670 | Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan |
| Q36744052 | Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice |
| Q35588665 | Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins |
| Q36951561 | Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms |
| Q37991383 | Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome |
| Q47713533 | Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth |
| Q34875675 | Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension |
| Q43932258 | Deficiency of volume-regulated ClC-3 chloride channel attenuates cerebrovascular remodelling in DOCA-salt hypertension |
| Q64967868 | Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar. |
| Q34341127 | Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome |
| Q34542559 | Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice. |
| Q38964342 | Drug Treatment of Hypertension: Focus on Vascular Health. |
| Q42648434 | Editorial Commentary: Understanding Marfan syndrome, or "how not to invent the light bulb". |
| Q47875235 | Effect of Losartan on Mitral Valve Changes After Myocardial Infarction |
| Q36583492 | Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14. |
| Q51024129 | Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV. |
| Q53603705 | Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity. |
| Q35390440 | Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness |
| Q38394699 | Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial |
| Q43162268 | Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats |
| Q37962590 | Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors |
| Q48218533 | Endothelial Cells Inhibit the Angiotensin II Induced Phenotypic Modulation of Rat Vascular Adventitial Fibroblasts. |
| Q80036050 | Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor |
| Q38870958 | Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling |
| Q34575283 | Essential role of Smad3 in angiotensin II-induced vascular fibrosis |
| Q33393631 | Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation |
| Q86210430 | Expression of transforming growth factor beta 1-related signaling proteins in irradiated vessels |
| Q89963758 | Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology |
| Q24546358 | Galectin-3 regulates myofibroblast activation and hepatic fibrosis |
| Q36042187 | Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension |
| Q37260211 | Genetic deletion of cell division autoantigen 1 retards diabetes-associated renal injury |
| Q41833631 | Gremlin activates the Smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells. |
| Q37272866 | Hereditary Influence in Thoracic Aortic Aneurysm and Dissection |
| Q42024077 | High concentrations of mast cell chymase facilitate the transduction of the transforming growth factor-β1/Smads signaling pathway in skin fibroblasts |
| Q36326008 | Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion |
| Q34634506 | Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice |
| Q41345639 | Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. |
| Q51750589 | Inhibition of cellular transdifferentiation by losartan minimizes but does not reverse type 2 diabetes-induced renal fibrosis. |
| Q35607297 | Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. |
| Q34355908 | Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation. |
| Q100750323 | Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q38423864 | Intracellular signaling of cardiac fibroblasts |
| Q53122857 | Irbesartan promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective long-term analysis. |
| Q36756427 | Lessons on the pathogenesis of aneurysm from heritable conditions |
| Q37955678 | Local renin-angiotensin systems in the genitourinary tract |
| Q37595616 | Losartan chemistry and its effects via AT1 mechanisms in the kidney |
| Q34582878 | Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors |
| Q24548457 | Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome |
| Q57184107 | Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy |
| Q51418425 | MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts. |
| Q36184322 | Matrix-dependent perturbation of TGFβ signaling and disease |
| Q43479307 | Mechanical stretch induces angiotensinogen expression through PARP1 activation in kidney proximal tubular cells. |
| Q37922113 | Mitral valve disease in Marfan syndrome and related disorders. |
| Q33807091 | Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets? |
| Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
| Q38694219 | New molecular insights in diabetic nephropathy |
| Q28543088 | No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice |
| Q33612309 | Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells |
| Q35978663 | Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis |
| Q34687503 | Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761. |
| Q38926505 | Peripheral and Cerebral Resistance Arteries in the Spontaneously Hypertensive Heart Failure Rat: Effects of Stilbenoid Polyphenols. |
| Q33579577 | Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. |
| Q35115765 | Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy. |
| Q30431214 | Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria |
| Q35884929 | Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats |
| Q37020964 | Prolonged fasting activates Nrf2 in post-weaned elephant seals. |
| Q90734035 | Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity |
| Q33717760 | Recapitulating and Correcting Marfan Syndrome in a Cellular Model |
| Q47119733 | Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor |
| Q38465654 | Regulators and effectors of bone morphogenetic protein signalling in the cardiovascular system. |
| Q36598311 | Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway |
| Q38598542 | Role of Smad signaling in kidney disease |
| Q35166254 | Role of TGF-β signaling in inherited and acquired myopathies |
| Q38738141 | Roles of the ERK1/2 and PI3K/PKB signaling pathways in regulating the expression of extracellular matrix genes in rat pulmonary artery smooth muscle cells |
| Q37700015 | SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan |
| Q44915757 | Smad3 initiates oxidative stress and proteolysis that underlies diaphragm dysfunction during mechanical ventilation. |
| Q52620425 | Smad3 mediates ANG II-induced hypertensive kidney disease in mice. |
| Q40169681 | Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells |
| Q35723980 | Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis |
| Q42136793 | Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis |
| Q41369308 | Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. |
| Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
| Q34798852 | TGF-β and restenosis revisited: a Smad link |
| Q37798974 | TGF-β signaling in aortic aneurysm: another round of controversy. |
| Q60922525 | TGFβ, smooth muscle cells and coronary artery disease: a review |
| Q89597844 | The Demonstration of an Aqp4/Tgf-beta 1 Pathway in Murine Astrocytes Holds Implications for Both Neuromyelitis Optica and Progressive Multiple Sclerosis |
| Q49180731 | The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature |
| Q38224257 | The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis |
| Q39008931 | The expression of Smad signaling pathway in myocardium and potential therapeutic effects |
| Q42186968 | The paradoxical TGF-β vasculopathies |
| Q37738226 | The pathogenesis of aortopathy in Marfan syndrome and related diseases |
| Q37524979 | The renin-angiotensin system: an old, newly discovered player in immunoregulation |
| Q35044636 | The revised role of TGF-β in aortic aneurysms in Marfan syndrome |
| Q36794938 | The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function |
| Q42231792 | The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model |
| Q36339426 | The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome |
| Q27001085 | Therapeutic strategies for preventing skeletal muscle fibrosis after injury |
| Q40952704 | Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models |
| Q39252052 | Thrombin-induced CCN2 expression in human lung fibroblasts requires the c-Src/JAK2/STAT3 pathway. |
| Q41814503 | Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment. |
| Q35895390 | Transforming growth factor beta signaling in adult cardiovascular diseases and repair. |
| Q37972665 | Transforming growth factor-β/Smad signalling in diabetic nephropathy. |
| Q99584180 | Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice |
| Q35184531 | Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis |
| Q26749488 | Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications |
| Q37344793 | Vascular disease in scleroderma |
| Q38930482 | Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall. |
| Q39413020 | miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling |
Search more.